Arrowhead Pharmaceuticals, Inc. (ARWR) Earnings History
Annual and quarterly earnings data from 1997 to 2025
Loading earnings history...
ARWR EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ARWR Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 97.1% | 11.9% | -0.2% |
| 2024 | -423.7% | -16927.1% | -16882.4% |
| 2023 | 94.8% | -85.2% | -85.3% |
| 2022 | 95.7% | -73.4% | -72.4% |
| 2021 | 0.0% | -107.8% | -101.9% |
Download Data
Export ARWR earnings history in CSV or JSON format
Free sign-in required to download data
Arrowhead Pharmaceuticals, Inc. (ARWR) Earnings Overview
As of May 8, 2026, Arrowhead Pharmaceuticals, Inc. (ARWR) reported trailing twelve-month net income of -$301M, reflecting +99.8% year-over-year growth. The company earned $-2.11 per diluted share over the past four quarters, with a net profit margin of -0.2%.
Looking at the long-term picture, ARWR's historical earnings data spans multiple years. The company achieved its highest annual net income of $68M in fiscal 2019.
Arrowhead Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ALNY ($577M net income, 8.4% margin), NTLA (-$413M net income, -609.9% margin), BEAM (-$65M net income, -57.2% margin), ARWR has room to improve margins relative to the peer group. Compare ARWR vs ALNY →
ARWR Earnings vs Peers
Earnings metrics vs comparable public companies
ARWR Historical Earnings Data (1997–2025)
29 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$2M | +99.7% | $98M | $-0.01 | -0.2% | 11.9% |
| 2024 | -$599M | -192.0% | -$601M | $-5.00 | -16882.4% | -16927.1% |
| 2023 | -$205M | -16.6% | -$205M | $-1.92 | -85.3% | -85.2% |
| 2022 | -$176M | -25.0% | -$179M | $-1.67 | -72.4% | -73.4% |
| 2021 | -$141M | -66.6% | -$149M | $-1.36 | -101.9% | -107.8% |
| 2020 | -$85M | -224.4% | -$93M | $-0.84 | -96.1% | -105.9% |
| 2019 | $68M | +224.8% | $61M | $0.69 | 40.3% | 36.3% |
| 2018 | -$54M | -58.4% | -$56M | $-0.65 | -337.3% | -346.5% |
| 2017 | -$34M | +57.9% | -$37M | $-0.47 | -109.5% | -117.8% |
| 2016 | -$82M | +11.1% | -$82M | $-1.34 | -51614.6% | -51627.1% |
Full ARWR Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ARWR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARWR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ARWR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonARWR — Frequently Asked Questions
Quick answers to the most common questions about buying ARWR stock.
Is ARWR growing earnings?
ARWR EPS is $-2.11, with earnings growth accelerating to +99.8%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-301M.
What are ARWR's profit margins?
Arrowhead Pharmaceuticals, Inc. net margin is -0.2%, with operating margin at +11.9%. Below-average margins reflect competitive or cost pressures.
How consistent are ARWR's earnings?
ARWR earnings data spans 1997-2025. The accelerating earnings trend is +99.8% YoY. Historical data enables comparison across business cycles.